calcium acetate phosphate binder
Selected indexed studies
- Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD). (Cochrane Database Syst Rev, 2018) [PMID:30132304]
- Calcium acetate versus calcium carbonate as oral phosphate binder in pediatric and adolescent hemodialysis patients. (Pediatr Nephrol, 1996) [PMID:8897570]
- Hyperphosphataemia: treatment options. (Drugs, 2013) [PMID:23625273]
_Worker-drafted node — pending editorial review._
Connections
calcium acetate phosphate binder is a side effect of
Sources
- Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD). (2018) pubmed
- Calcium acetate versus calcium carbonate as oral phosphate binder in pediatric and adolescent hemodialysis patients. (1996) pubmed
- Hyperphosphataemia: treatment options. (2013) pubmed
- The phosphate binder equivalent dose. (2011) pubmed
- Calcium acetate or calcium carbonate for hyperphosphatemia of hemodialysis patients: a meta-analysis. (2015) pubmed
- Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD). (2025) pubmed
- Use of alkaline calcium salts as phosphate binder in uremic patients. (1992) pubmed
- Effectiveness of calcium acetate as a phosphate binder in patients undergoing continuous ambulatory peritoneal dialysis. (1998) pubmed
- Effect of the Phosphate Binders Sevelamer Carbonate and Calcium Acetate on the Pharmacokinetics of Roxadustat After Concomitant or Time-separated Administration in Healthy Individuals. (2021) pubmed
- Comparison of calcium acetate with calcium carbonate as phosphate binder in patients on maintenance haemodialysis. (2007) pubmed